D-0632-2024 Class II Ongoing

Recalled by FDC Limited — Aurangabad, Maharashtra State

FDA drug recall D-0632-2024 was initiated by FDC Limited on Jul 18, 2024 and is designated Class II. Reason for recall: Defective container; yellow colored spike from cap lodged in the nozzle The recall status is ongoing. Affected quantity: 362,544 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 21, 2024
Initiation Date
Jul 18, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
362,544 bottles

Product description

Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, [NDC 64980-514-05].

Reason for recall

Defective container; yellow colored spike from cap lodged in the nozzle

Distribution pattern

Nationwide in the US

Code information

Lot Number: 083J022, Expiration Date: September- 25; 083L046, Expiration date: November- 25; 083H009, Expiration date: July- 25

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0632-2024
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0632-2024. Report a data issue: hello@regdatalab.com.